1-161791522-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007348.4(ATF6):​c.469C>T​(p.Pro157Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0939 in 1,607,720 control chromosomes in the GnomAD database, including 12,636 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1613 hom., cov: 32)
Exomes 𝑓: 0.091 ( 11023 hom. )

Consequence

ATF6
NM_007348.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.453

Publications

27 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002713263).
BP6
Variant 1-161791522-C-T is Benign according to our data. Variant chr1-161791522-C-T is described in ClinVar as Benign. ClinVar VariationId is 1164407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.3 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATF6NM_007348.4 linkc.469C>T p.Pro157Ser missense_variant Exon 5 of 16 ENST00000367942.4 NP_031374.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATF6ENST00000367942.4 linkc.469C>T p.Pro157Ser missense_variant Exon 5 of 16 1 NM_007348.4 ENSP00000356919.3

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
18003
AN:
151992
Hom.:
1598
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.135
Gnomad AMI
AF:
0.0275
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.313
Gnomad SAS
AF:
0.0940
Gnomad FIN
AF:
0.0692
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.0712
Gnomad OTH
AF:
0.122
GnomAD2 exomes
AF:
0.149
AC:
36827
AN:
247808
AF XY:
0.133
show subpopulations
Gnomad AFR exome
AF:
0.135
Gnomad AMR exome
AF:
0.450
Gnomad ASJ exome
AF:
0.0973
Gnomad EAS exome
AF:
0.310
Gnomad FIN exome
AF:
0.0690
Gnomad NFE exome
AF:
0.0718
Gnomad OTH exome
AF:
0.116
GnomAD4 exome
AF:
0.0913
AC:
132966
AN:
1455610
Hom.:
11023
Cov.:
31
AF XY:
0.0897
AC XY:
64986
AN XY:
724352
show subpopulations
African (AFR)
AF:
0.133
AC:
4430
AN:
33288
American (AMR)
AF:
0.429
AC:
18934
AN:
44104
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2723
AN:
25998
East Asian (EAS)
AF:
0.342
AC:
13458
AN:
39392
South Asian (SAS)
AF:
0.0855
AC:
7353
AN:
85958
European-Finnish (FIN)
AF:
0.0650
AC:
3347
AN:
51522
Middle Eastern (MID)
AF:
0.0957
AC:
551
AN:
5758
European-Non Finnish (NFE)
AF:
0.0685
AC:
76039
AN:
1109390
Other (OTH)
AF:
0.102
AC:
6131
AN:
60200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
5199
10398
15598
20797
25996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3174
6348
9522
12696
15870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.119
AC:
18047
AN:
152110
Hom.:
1613
Cov.:
32
AF XY:
0.122
AC XY:
9047
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.136
AC:
5623
AN:
41464
American (AMR)
AF:
0.269
AC:
4110
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
352
AN:
3472
East Asian (EAS)
AF:
0.313
AC:
1616
AN:
5160
South Asian (SAS)
AF:
0.0933
AC:
450
AN:
4824
European-Finnish (FIN)
AF:
0.0692
AC:
733
AN:
10588
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0712
AC:
4841
AN:
68008
Other (OTH)
AF:
0.127
AC:
268
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
769
1538
2308
3077
3846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.100
Hom.:
2659
Bravo
AF:
0.140
TwinsUK
AF:
0.0707
AC:
262
ALSPAC
AF:
0.0739
AC:
285
ESP6500AA
AF:
0.130
AC:
573
ESP6500EA
AF:
0.0736
AC:
633
ExAC
AF:
0.137
AC:
16680
Asia WGS
AF:
0.255
AC:
888
AN:
3476
EpiCase
AF:
0.0733
EpiControl
AF:
0.0755

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
15
DANN
Benign
0.95
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.6
L
PhyloP100
0.45
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.059
Sift
Benign
0.21
T
Sift4G
Benign
0.65
T
Polyphen
0.031
B
Vest4
0.039
MPC
0.15
ClinPred
0.0019
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.028
gMVP
0.30
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1135983; hg19: chr1-161761312; COSMIC: COSV63406311; API